ImmunoPET Imaging of Renal Cell Carcinoma with I-124- and Zr-89-Labeled Anti-CAIX Monoclonal Antibody cG250 in Mice

A.B. Stillebroer; G.M. Franssen; P.F.A. Mulders; W.J.G. Oyen; G.A.M.S. van Dongen; P. Laverman; E Oosterwijk; OC Boerman

doi:https://doi.org/10.1089/cbr.2013.1487

ImmunoPET Imaging of Renal Cell Carcinoma with I-124- and Zr-89-Labeled Anti-CAIX Monoclonal Antibody cG250 in Mice

A.B. Stillebroer, G.M. Franssen, P.F.A. Mulders, W.J.G. Oyen, G.A.M.S. van Dongen, P. Laverman, E Oosterwijk, OC Boerman

Research output: Contribution to journal › Article › Academic › peer-review

49 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	510-515
Journal	Cancer Biotherapy and Radiopharmaceuticals
Volume	28
Issue number	7
DOIs	https://doi.org/10.1089/cbr.2013.1487
Publication status	Published - 2013

Access to Document

https://doi.org/10.1089/cbr.2013.1487

Cite this

@article{6a8daee53fae4c47b840f832021421cb,

title = "ImmunoPET Imaging of Renal Cell Carcinoma with I-124- and Zr-89-Labeled Anti-CAIX Monoclonal Antibody cG250 in Mice",

author = "A.B. Stillebroer and G.M. Franssen and P.F.A. Mulders and W.J.G. Oyen and {van Dongen}, G.A.M.S. and P. Laverman and E Oosterwijk and OC Boerman",

year = "2013",

doi = "https://doi.org/10.1089/cbr.2013.1487",

language = "Undefined/Unknown",

volume = "28",

pages = "510--515",

journal = "Cancer Biotherapy and Radiopharmaceuticals",

issn = "1084-9785",

publisher = "Mary Ann Liebert Inc.",

number = "7",

}

TY - JOUR

T1 - ImmunoPET Imaging of Renal Cell Carcinoma with I-124- and Zr-89-Labeled Anti-CAIX Monoclonal Antibody cG250 in Mice

AU - Stillebroer, A.B.

AU - Franssen, G.M.

AU - Mulders, P.F.A.

AU - Oyen, W.J.G.

AU - van Dongen, G.A.M.S.

AU - Laverman, P.

AU - Oosterwijk, E

AU - Boerman, OC

PY - 2013

Y1 - 2013

U2 - https://doi.org/10.1089/cbr.2013.1487

DO - https://doi.org/10.1089/cbr.2013.1487

M3 - Article

C2 - 23697926

SN - 1084-9785

VL - 28

SP - 510

EP - 515

JO - Cancer Biotherapy and Radiopharmaceuticals

JF - Cancer Biotherapy and Radiopharmaceuticals

IS - 7

ER -